Biomedical Engineering Reference
In-Depth Information
149. Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, Sawada Y.
2005. Citrus juices inhibit the function of human organic anion-transporting polypeptide
OATP-B. Drug Metab Dispos 33(4):518-523.
150. Sai Y, Kaneko Y, Ito S, Mitsuoka K, Kato Y, Tamai I, Artursson P, Tsuji A. 2006. Pre-
dominant Contribution of organic anion transporting polypeptide OATP-B (OATP2B1)
to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells. Drug Metab
Dispos 34(8):1423-1431.
151. Fuchikami H, Satoh H, Tsujimoto M, Ohdo S, Ohtani H, Sawada Y. 2006. Effects
of herbal extracts on the function of human organic anion-transporting polypeptide
OATP-B. Drug Metab Dispos 34(4):577-582.
152. Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, Onogawa T, Suzuki T,
Asano N, Tanemoto M, et al. 2001. Identification of thyroid hormone transporters in
humans: different molecules are involved in a tissue-specific manner. Endocrinology
142(5):2005-2012.
153. Iida A, Saito S, Sekine A, Mishima C, Kondo K, Kitamura Y, Harigae S, Osawa S, Naka-
mura Y. 2001. Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding
three organic anion transporters, three organic anion-transporting polypeptides, and
three NADH:ubiquinone oxidoreductase flavoproteins. J Hum Genet 46(11):668-683.
154. Iwai M, Suzuki H, Ieiri I, Otsubo K, Sugiyama Y. 2004. Functional analysis of single
nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).
Pharmacogenetics 14(11):749-757.
155. Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum
M, Keppler D, Konig J. 2002. A naturally occurring mutation in the SLC21A6 gene
causing impaired membrane localization of the hepatocyte uptake transporter. J Biol
Chem 277(45):43058-43063.
156. Schwarz UI, Seemann D, Oertel R, Miehlke S, Kuhlisch E, Fromm MF, Kim RB,
Bailey DG, Kirch W. 2005. Grapefruit juice ingestion significantly reduces talinolol
bioavailability. Clin Pharmacol Ther 77(4):291-301.
157. Koitabashi Y, Kumai T, Matsumoto N, Watanabe M, Sekine S, Yanagida Y, Kobayashi
S. 2006. Orange juice increased the bioavailability of pravastatin, 3-hydroxy-3-
methylglutaryl CoA reductase inhibitor, in rats and healthy human subjects. Life Sci
78(24):2852-2859.
158. Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ. 2003. Gemfibrozil increases
plasma
pravastatin
concentrations
and
reduces
pravastatin
renal
clearance.
Clin
Pharmacol Ther 73(6):538-544.
159. Schneck DW, Birmingham BK, Zalikowski JA, Mitchell PD, Wang Y, Martin PD,
Lasseter KC, Brown CD, Windass AS, Raza A. 2004. The effect of gemfibrozil on the
pharmacokinetics of rosuvastatin. Clin Pharmacol Ther 75(5):455-463.
160. Muck W, Mai I, Fritsche L, Ochmann K, Rohde G, Unger S, Johne A, Bauer S, Budde
K, Roots I, Neumayer HH, Kuhlmann J. 1999. Increase in cerivastatin systemic exposure
after single and multiple dosing in cyclosporine-treated kidney transplant recipients.
Clin Pharmacol Ther 65(3):251-261.
161. Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ. 2002. Gemfibrozil greatly
increases plasma concentrations of cerivastatin. Clin Pharmacol Ther 72(6):685-691.
Search WWH ::
Custom Search